Bullish
Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research
Veradermics, Incorporated (NYSE: MANE) announced that topline results from its Phase 2/3 ‘302’ study of VDPHL01 will be presented at the 2026 World Co...